Here’s How LVS Advisory Embraced Change in Medpace Holdings (MEDP) Investments
LVS Advisory, a New York City-based full-service investment firm, recently released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Medpace Holdings Inc. (MEDP)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 553,588 | $183,918,541 | +13% | 0.27% |
| 2. | AQR Capital Management Cliff Asness | 480,186 | $159,532,325 | +32% | 0.2% |
| 3. | Giverny Capital Francois Rochon | 234,287 | $77,837,170 | +4% | 2.84% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 212,500 | $70,598,875 | +13% | 0.16% |
| 5. | Fisher Asset Management Ken Fisher | 183,353 | $60,915,512 | +48% | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $326.11 | 2 | Officer | 13,343 | 2025-02-27 | Filing | |
| $154.59 | 57,426 | Large Shareholder | 6,483,019 | 2022-09-22 | Filing | |
| $154.59 | 57,426 | Large Shareholder, Officer, Director | 6,483,019 | 2022-09-22 | Filing | |
| $161.63 | 94,119 | Large Shareholder, Officer, Director | 6,425,593 | 2022-09-21 | Filing | |
| $155.14 | 94,119 | Large Shareholder, Officer, Director | 6,331,474 | 2022-09-20 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $345.59 | 4,003 | Director | 26,032 | 2025-02-24 | Filing | |
| $390.73 | 3,774 | Director | 520 | 2024-08-23 | Filing | |
| $390.73 | 4,353 | Director | 520 | 2024-08-22 | Filing | |
| $401.20 | 7,681 | Officer | 7,500 | 2024-06-05 | Filing | |
| $395.49 | 5,695 | Large Shareholder, Officer, Director | 654,656 | 2024-05-28 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,727,257 | $906,076,588 | 0.01% | |
| 2. | 2,570,770 | $854,086,917 | 0.01% | |
| 3. | 1,084,753 | $360,387,489 | 0.06% | |
| 4. | 936,842 | $311,247,018 | 1.54% | |
| 5. | 779,814 | $259,077,605 | 0.01% |
News See All
12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
Here are the Reasons to Invest in Medpace Holdings (MEDP)
Madison Investments, an investment advisor, released its “Madison Small Cap Fund” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Medpace Holdings, Inc. (MEDP): A Bull Case Theory
We came across a bullish thesis on Medpace Holdings, Inc. (MEDP) on Substack by Long-Term Pick. In this article, we will summarize the bulls’ thesis on MEDP. Medpace Holdings, Inc.
Medpace Holdings, Inc. (NASDAQ:MEDP) Q4 2024 Earnings Call Transcript
Operator: And good day, ladies and gentlemen, and welcome to the Medpace Holdings, Inc. Fourth Quarter and Full Year 2024 Earnings Conference Call.
Here are Giverny Capital Asset Management’s Updates on Medpace Holdings (MEDP)
Giverny Capital Asset Management, LLC, an investment management company, recently published its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
What Makes Medpace Holdings (MEDP) a Promising Investment?
Investment management company Vulcan Value Partners recently released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Lower than Expected Results Dragged Medpace Holdings (MEDP) in Q3
Wasatch Global Investors, an asset management company, released its “Wasatch Small Cap Growth Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
What Makes Medpace Holdings (MEDP) a Good Holding?
Giverny Capital Asset Management, LLC, an investment management company, recently published its third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Medpace Holdings, Inc. (NASDAQ:MEDP) Q3 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Medpace Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.